Skip to main content
PMC home page
Clinical Cardiology logoLink to Clinical Cardiology
. 2010 Mar 16;33(3):140–148. doi: 10.1002/clc.20718

Acute ST‐elevation Myocardial Infarction in Young Patients: 15 Years of Experience in a Single Center

Su‐Kiat Chua 1, Huei‐Fong Hung 1,2, Kou‐Gi Shyu 1,3, Jun‐Jack Cheng 1,2, Chiung‐Zuan Chiu 1,2, Che‐Ming Chang 1,2, Sheng‐Chang Lin 1, Jer‐Young Liou 1, Huey‐Ming Lo 1,2, Peiliang Kuan 1, Shih‐Huang Lee 1,2,✉
PMCID: PMC6653652  PMID: 20235218

Abstract

Background:

There have been few studies done regarding young patients with ST‐elevation myocardial infarction (STEMI). The purpose of this study was to investigate the clinical characteristics and coronary angiographic features in young patients with STEMI.

Methods:

We collected data on 849 consecutive patients with STEMI from 1992 to 2006. Baseline clinical characteristics, coronary anatomy, and outcome were compared in young (≤45 yrs) and older patients (>45 yrs).

Results:

Young patients presented 11.6% of all patients with STEMI. These patients were predominantly male (92.9% vs 80.3%, P < 0.001), more likely to smoke (75.8% vs 47.2%, P < 0.001), obese (48.2% vs 27.9%, P = 0.002), have higher triglyceride levels (176.9 ± 153.8 mg/dL vs 140.7 ± 112.7 mg/dL, P = 0.005), and lower high‐density lipoprotein cholesterol (37.1 ± 7.9 mg/dL vs 42.8 ± 14.3 mg/dL, P = 0.005) than older patients. Also, younger patients had a shorter hospital stay (7.1 ± 4.9 d vs 8.5 ± 6.7 d, P = 0.04), less in‐hospital morbidity (29.3% vs 39.7%, P = 0.02), and mortality (3.0% vs 12.3%, P = 0.002). Killip class III or IV could predict in‐hospital morbidity and mortality in young patients. Both groups had similar rates of repeated percutaneous coronary intervention (PCI; 45.5% vs 41.5%, P = 0.23) and reinfarction (6.1% vs 3.2%, P = 0.32). Mortality rate during follow‐up was significantly lower in younger patients (3.0% vs 19.6%, P < 0.001).

Conclusion:

Cigarette smoking, obesity, and dyslipidemia were the most important modifiable risk factors in young patients with STEMI. These patients had a better outcome than older patients without differences in repeated PCI and reinfarction between them. Only Killip class III or IV could predict in‐hospital morbidity and mortality in young patients with STEMI. Copyright © 2010 Wiley Periodicals, Inc.

Full Text

The Full Text of this article is available as a PDF (133.4 KB).

References

  • 1. Doughty M, Mehta R, Bruckman D, et al. Acute myocardial infarction in the young: the University of Michigan experience. Am Heart J 2002; 143: 56–62. [DOI] [PubMed] [Google Scholar]
  • 2. Moccetti T, Malacrida R, Pasotti E, et al. Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction. Arch Intern Med 1997; 157: 865–869. [PubMed] [Google Scholar]
  • 3. Barbash GI, White HD, Modan M, et al. Acute myocardial infarction in the young: the role of smoking. Eur Heart J 1995; 16: 313–316. [PubMed] [Google Scholar]
  • 4. Zimmerman FH, Cameron A, Fisher LD, et al. Myocardial infarction in young patients: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). J Am Coll Cardiol 1995; 26: 654–661. [DOI] [PubMed] [Google Scholar]
  • 5. Choudhury L, Marsh JD. Myocardial infarction in young patients. Am J Med 1999; 107: 254–261. [DOI] [PubMed] [Google Scholar]
  • 6. Egred M, Viswanathan G, Davis GK. Myocardial infarction in young patients. Postgrad Med 2005; 81: 741–745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Pineda J, Marin F, Roldan V, et al. Premature myocardial infarction: clinical profile and angiographic findings. Int J Cardiol 2008; 126: 127–129. [DOI] [PubMed] [Google Scholar]
  • 8. Ismail J, Jafar TH, Jafary FH, et al. Risk factors for non‐fatal myocardial infarction in young South Asian patients. Heart 2004; 90: 259–263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Colkesen AY, Acil T, Demircan S, et al. Coronary lesion type, location, and characteristics of acute ST elevation myocardial infarction in young patients under 35 years of age. Coronary Artery Dis 2008; 19: 345–347. [DOI] [PubMed] [Google Scholar]
  • 10.WHO expert consultation. Appropriate body‐mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 157–163. [DOI] [PubMed] [Google Scholar]
  • 11. Kanitz MG, Giovannucci SJ, Jones JS, et al. Myocardial infarction in young patients: risk factors and clinical features. J Emerg Med 1996; 14: 139–145. [DOI] [PubMed] [Google Scholar]
  • 12. Cahtelli WP. Epidemiology of coronary heart disease: the Framingham Study. Am J Med 1984; 76: 4–12. [DOI] [PubMed] [Google Scholar]
  • 13. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Arch Intern Med 1992; 152: 56–64. [PubMed] [Google Scholar]
  • 14. Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation 1992; 85: 37–45. [DOI] [PubMed] [Google Scholar]
  • 15. Gaziano JM, Hennekens CH, O'Donnell CJ. Fasting triglycerides, high‐density lipoprotein, and risk of myocardial infarction. Circulation 1007; 96: 2520–2525. [DOI] [PubMed] [Google Scholar]
  • 16. Chen L, Chester M, Kaski JC. Clinical factors and angiographic features associated with premature coronary artery disease. Chest 1995; 108: 364–369. [DOI] [PubMed] [Google Scholar]
  • 17. Bittner V, Johnson BD, Pharm IZ, et al. The triglyceride/high‐density lipoprotein cholesterol ratio predicts all‐cause mortality in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE). Am Heart J 2009; 157: 548–555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005; 112: 2735–2752. [DOI] [PubMed] [Google Scholar]
  • 19. Wienbergen H, Gitt AK, Juenger C, et al. Impact of the body mass index on occurrence and outcome of acute ST‐elevation myocardial infarction. Clin Res Cardiol 2008; 97: 83–88. [DOI] [PubMed] [Google Scholar]
  • 20.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Patients. Third report of National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Patients (Adult Treatment Panel III): final report. Circulation 2002; 106: 3143–3421. [PubMed] [Google Scholar]
  • 21. Takeno M, Yasuda S, Otsuka Y, et al. Impact of metabolic syndrome on the long‐term survival of patients with acute myocardial infarction: potential association with C‐reactive protein. Circ J 2008; 72: 415–419. [DOI] [PubMed] [Google Scholar]
  • 22. Chung EH, Curran PJ, Sivasankaran S, et al. Prevalence of metabolic syndrome in patients ≤ 45 years of age with acute myocardial infarction having percutaneous coronary intervention. Am J Cardiol 2007; 100: 1052–1055. [DOI] [PubMed] [Google Scholar]
  • 23. Kofflard M, de Jaegere P, van Domburg R, et al. Immediate and long‐term clinical outcome of coronary angioplasty in patients aged 35 years or less. Br Heart J 1995; 73: 82–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Second International Study of Infarct Survival‐Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17187 cases of suspected acute myocardial infarction: ISIS‐2. Lancet 1988; 2: 349–360. [PubMed] [Google Scholar]
  • 25.The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821–828. [PubMed] [Google Scholar]
  • 26. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST‐elevation myocardial infarction: executive summary. J Am Coll Cardiol 2004; 44: 671–719. [DOI] [PubMed] [Google Scholar]
  • 27. Chen ZM, Pan HC, Chen YP, et al; COMMIT (Clopidogrel and Metoprolol in Myocardial Infarction Trial) Collaborative Group. Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomized placebo‐controlled trial. Lancet 2005; 366: 1622–1632. [DOI] [PubMed] [Google Scholar]
  • 28. Barbash GI, White HD, Modan M, et al. Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Circulation 1993; 87: 53–58. [DOI] [PubMed] [Google Scholar]
  • 29. Genest JJ, Corbett HM, McNamara JR, et al. Effect of hospitalization on high‐density lipoprotein cholesterol in patients undergoing elective coronary angiography. Am J Cardiol 1988; 61: 998–1000. [DOI] [PubMed] [Google Scholar]
  • 30. Genest JJ, McNamara JR, Ordovas JM, et al. Effect of hospitalization on plasma lipoprotein cholesterol and apoliproteins A‐I, B and Lp(a). Am J Cardiol 1990; 65: 677–679. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES